Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.23.2
Document And Entity Information - shares
 6 Months Ended
Jun. 30, 2023
Aug. 10, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 001-36291  
Entity Registrant Name DIAMEDICA THERAPEUTICS INC.  
Entity Incorporation, State or Country Code A1  
Entity Address, Address Line One 301 Carlson Parkway, Suite 210  
Entity Address, City or Town Minneapolis  
Entity Address, State or Province MN  
Entity Address, Postal Zip Code 55305  
City Area Code 763  
Local Phone Number 496-5454  
Title of 12(b) Security Voting common shares, no par value per share  
Trading Symbol DMAC  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   37,949,422
Entity Central Index Key 0001401040  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false